Yangjun Cai

Taizhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Real-world outcomes of CDK4/6 inhibitors in combination with endocrine therapy as first-line treatment for HR-positive/HER2-negative advanced breast cancer: multicenter evidence from China.

Real-world outcomes of CDK4/6 inhibitors in combination with endocrine therapy as first-line treatment for HR-positive/HER2-negative advanced breast cancer: multicenter evidence from China.

Journal: BMC cancer
Published: January 23, 2026

The xCT/CD98 complex suppresses ferroptosis in pan-cancer via a non-canonical RACK1-mediated iron homeostasis pathway.

The xCT/CD98 complex suppresses ferroptosis in pan-cancer via a non-canonical RACK1-mediated iron homeostasis pathway.

Journal: Cell reports
Published: June 12, 2025

5-Hydroxymethylcytosine signatures in circulating cell-free DNA as potential diagnostic markers for breast cancer.

5-Hydroxymethylcytosine signatures in circulating cell-free DNA as potential diagnostic markers for breast cancer.

Journal: Biomarkers in medicine
Published: March 26, 2025

TET-mediated 5hmC in breast cancer: mechanism and clinical potential.

TET-mediated 5hmC in breast cancer: mechanism and clinical potential.

Journal: Epigenetics
Published: February 27, 2025

Serum Direct Bilirubin as a Biomarker for Breast Cancer.

Serum Direct Bilirubin as a Biomarker for Breast Cancer.

Journal: Breast cancer (Dove Medical Press)
Published: August 14, 2024

A potential therapeutic molecule target: lncRNA AK023507 inhibits the metastasis of breast cancer by regulating the WNT/DOCK4/β-catenin axis.

A potential therapeutic molecule target: lncRNA AK023507 inhibits the metastasis of breast cancer by regulating the WNT/DOCK4/β-catenin axis.

Journal: Breast cancer research and treatment
Published: June 17, 2024

M6A RNA Methylation-Mediated Dysregulation of AGAP2-AS1 Promotes Trastuzumab Resistance of Breast Cancer.

M6A RNA Methylation-Mediated Dysregulation of AGAP2-AS1 Promotes Trastuzumab Resistance of Breast Cancer.

Journal: Pharmacology
Published: April 10, 2023

The construction and analysis of a prognostic assessment model based on P53-related multi-genes in breast carcinoma.

The construction and analysis of a prognostic assessment model based on P53-related multi-genes in breast carcinoma.

Journal: European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)
Published: March 13, 2023

Novel LncRNA AK023507 inhibits cell metastasis and proliferation in Papillary Thyroid Cancer through β-catenin/Wnt Signaling Pathway.

Novel LncRNA AK023507 inhibits cell metastasis and proliferation in Papillary Thyroid Cancer through β-catenin/Wnt Signaling Pathway.

Journal: Biochemical and biophysical research communications
Published: February 27, 2023

ARIH1 activates STING-mediated T-cell activation and sensitizes tumors to immune checkpoint blockade.

ARIH1 activates STING-mediated T-cell activation and sensitizes tumors to immune checkpoint blockade.

Journal: Nature communications
Published: December 07, 2022

Effects of Tamoxifen vs. Toremifene on fatty liver development and lipid profiles in breast Cancer.

Effects of Tamoxifen vs. Toremifene on fatty liver development and lipid profiles in breast Cancer.

Journal: BMC cancer
Published: December 05, 2020

Long Non-Coding RNA NLIPMT as a Tumor Suppressor and Inhibitor of Cell Proliferation and Metastasis in Papillary Thyroid Carcinoma.

Long Non-Coding RNA NLIPMT as a Tumor Suppressor and Inhibitor of Cell Proliferation and Metastasis in Papillary Thyroid Carcinoma.

Journal: Cancer management and research
Published: June 09, 2020
Showing 1-12 of 13

Last Updated: 09/26/2026